Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Ipsogen

1999 FOUNDED
M&A STATUS
PIPE LATEST DEAL TYPE
5 FINANCING ROUNDS
Description

Provider of molecular testing services. The company develops and markets innovative molecular diagnostic tools to clinical centers and hospitals world-wide through its onco-diagnostics business units and provides monitoring of many types of blood cancers as well as the selection and guidance of therapies.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Acquirer
Primary Office
  • Luminy Biotech Entreprises
  • Case 923 - 163 Ave de Luminy
  • 13288 Marseille
  • France

+33 04 00 00 00 00

Ipsogen Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Ipsogen‘s full profile, request access.

Request full access to PitchBook

Ipsogen Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Ipsogen‘s full profile, request access.

Request full access to PitchBook

Ipsogen Executive Team (3)

Name Title Board
Seat
Contact
Info
Vincent Fert Chief Executive Officer & President

2 Former Executives

You’re viewing 1 of 3 executives. Get the full list »

Ipsogen Board Members (2)

Name Representing Role Since Contact
Info
000000000 00000000 00.0 Self Board Member 000 0000

1 Former Board Member

You’re viewing 1 of 2 board members. Get the full list »